---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020312"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2023-06-06T23:59:59+00:00"
generated_at: "2026-06-14T06:39:54.873368+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Oncocyte presents at LD Micro Invitational; slides furnished but no material new info disclosed

## Summary
- Presented at 13th Annual LD Micro Invitational on June 6, 2023 in Los Angeles.
- Presentation slides furnished as Exhibit 99.1; no specific financial or operational updates extracted.
- No forward-looking guidance or material events announced in the filing text.

## SEC filing metadata
- accession: 0001493152-23-020312
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2023-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000149315223020312/0001493152-23-020312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000149315223020312/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020312
- JSON: https://secwatch.observer/filing/0001493152-23-020312.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020312.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.